ArticleMicroorganisms2025

Assessment of Eravacycline Antimicrobial Susceptibility in China During the First Year Following Regulatory Approval (2023-2024): A Real-World Study.

Qiaolian Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.